Snowden Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
4,817
+246
+5% +$10.6K 0.01% 1208
2025
Q4
$200K Buy
+4,571
New +$189K 0.01% 1222
2023
Q1
Sell
-26,170
Closed -$420K 1161
2022
Q4
$420K Buy
26,170
+1,924
+8% +$31.4K 0.02% 783
2022
Q3
$380K Buy
24,246
+7,807
+47% +$151K 0.02% 779
2022
Q2
$342K Buy
+16,439
New +$339K 0.02% 808

Other funds holding EXEL

Snowden Capital Advisors's EXEL Position: Q1 2026 in Review

Snowden Capital Advisors increased its Exelixis (EXEL) stake by 5.4% in Q1 2026, buying an estimated $10.6K and bringing the position to 4,817 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #1208.

Snowden Capital Advisors first reported a position in EXEL in Q2 2022 and has held it in 5 quarters since. The position peaked at $420K in Q4 2022. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Snowden Capital Advisors held 4,817 shares of Exelixis worth $207K as of Q1 2026.
  • Snowden Capital Advisors bought 246 Exelixis shares in Q1 2026, an estimated $10.6K.
  • Exelixis made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1208 holding.
  • Snowden Capital Advisors first reported a position in Exelixis in Q2 2022 and has held it in 5 quarters since.
  • Snowden Capital Advisors's Exelixis position peaked at $420K in Q4 2022.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.